In our current research, both caspase-1 inhibitors do not display significant inhibitory effects on TAM’s cell viability or growth, but leads to the disruption of PPARγ/MCAD activity and repolarization/reprogramming of TAMs, eventually suppressing the tumor growth. This evidence concerns the gene CASP1 and neoplasm.